News Feature Channel: Liver Disease

Jacob Bilhartz, M.D., Available to Discuss Vitamin A Supplements and Potential Liver Injury in Children

Michigan Medicine - University of Michigan — Fri, 28 Mar 2025 18:30:34 EST

Yale Surgeons to Present at International Surgical Oncology Conference

Yale Cancer Center/Smilow Cancer Hospital — Mon, 24 Mar 2025 10:55:32 EST

Yale Department of Surgery oncologists and trainees at Yale Cancer Center will present new findings at the Society of Surgical Oncology (SSO) Annual Meeting in Tampa, Fla., from March 27-29. The conference focuses on improving surgical cancer care for patients through educational sessions as well as oral and poster presentations for surgical oncologists, researchers, and patient advocates.

Cedars-Sinai Appoints New Chair of Department of Medicine

Cedars-Sinai — Thu, 20 Mar 2025 23:35:42 EST

Following a comprehensive national search, Cedars-Sinai has appointed David E. Cohen, MD, PhD, as the new chair of the Department of Medicine, effective July 1.

Liver Supplements - Hype or Harm?

Hackensack Meridian Health — Tue, 18 Mar 2025 09:10:53 EST

Unlocking the Secrets of HBV: New Hope for Chronic Hepatitis B Cure

Chinese Academy of Sciences — Mon, 17 Mar 2025 11:00:02 EST

Chronic hepatitis B virus (HBV) infection continues to pose a major global health threat. The virus evades immune responses and antiviral therapies due to the persistence of covalently closed circular DNA (cccDNA), which serves as a viral reservoir.

GLP-1 Use Before Endoscopy, Resuming Blood Thinners after ESD, and More in the March Issue of AJG

American College of Gastroenterology (ACG) — Mon, 10 Mar 2025 19:35:02 EST

In the March issue of The American Journal of Gastroenterology: The effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) on gastric retention before endoscopy, resumption of blood thinners after colorectal submucosal dissection, and the utility of inpatient GI consults to clear patients for transesophageal echocardiogram.

Diesel Exhaust Exposure Led to Disarray in Liver Function in Mice

University of California, Los Angeles (UCLA), Health Sciences — Tue, 04 Mar 2025 11:00:04 EST

STIM1: The Cancer Shield Against Sorafenib Unmasked

Chinese Academy of Sciences — Tue, 04 Mar 2025 08:20:58 EST

A recent study unveils how stromal interaction molecule 1 (STIM1), a protein involved in calcium signaling, plays a pivotal role in the resistance of liver cancer to sorafenib, a key treatment for advanced hepatocellular carcinoma (HCC).

Metabolic Shift in Liver Cancer: How PDHX Acetylation Drives Tumor Growth

Chinese Academy of Sciences — Mon, 03 Mar 2025 05:50:37 EST

A recent study has unveiled a new mechanism driving hepatocellular carcinoma (HCC) progression through the acetylation of pyruvate dehydrogenase complex (PDC) component X (PDHX), a critical component of the PDC. This modification disrupts PDC assembly, inhibits its function, and shifts metabolism towards aerobic glycolysis, promoting tumor growth. The findings highlight PDHX acetylation as both a potential biomarker and therapeutic target, offering new possibilities for liver cancer treatment and advancing our understanding of cancer cell metabolism.

Cedars-Sinai Sets New Record in Organ Transplantation

Cedars-Sinai — Fri, 28 Feb 2025 18:45:11 EST

The Cedars-Sinai Comprehensive Transplant Center and the Smidt Heart Institute set a new record in 2024 by completing 682 solid organ transplants--the most the medical center has performed in a year--as patient survival outcomes continued to meet or exceed the national average.

Artificial Intelligence Helps Find Undiagnosed Liver Disease

Cedars-Sinai — Thu, 27 Feb 2025 19:10:40 EST

An artificial intelligence (AI) program can identify chronic liver disease from videos taken during a common heart test known as an echocardiogram, Cedars-Sinai investigators report.

How Solving a Hepatitis B Paradox Opened the Door to New Therapies

Rockefeller University — Thu, 27 Feb 2025 16:50:21 EST

Procedimiento doble combina trasplante de higado y cirugia bariatrica

Mayo Clinic — Thu, 27 Feb 2025 11:10:02 EST

Cirujanos de Mayo Clinic descubrieron que un enfoque innovador puede ayudar a los pacientes con obesidad a recibir atencion vital. La obesidad puede ser una barrera para el transplante de higado. La Dra. Julie Heimbach, directora del Centro de Trasplantes de Mayo Clinic en Rochester, Minnesota, afirma que la combinacion de la cirugia de manga gastrica, un tipo de cirugia bariatrica, con el trasplante de higado, es eficaz para hacer frente a ambos problemas de salud.

Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: Challenges and opportunities

World Journal of Stem Cells — Wed, 26 Feb 2025 12:00:34 EST

The potential of induced pluripotent stem cells (iPSCs) for modeling and treating metabolic associated fatty liver disease (MAFLD) and metabolic associated steatohepatitis (MASH) is emerging. MAFLD is a growing global health concern, curren

Yale Gynecology Chair: Endometriosis-Associated microRNAs Impact Liver Metabolism

Yale School of Medicine — Mon, 24 Feb 2025 18:55:29 EST

Study: Endometriosis-Linked microRNAs Help Regulate Liver Metabolism

Yale School of Medicine — Mon, 24 Feb 2025 17:40:57 EST

'Deaths of Despair' More than Double in the U.S. Over Two Decades

Florida Atlantic University — Thu, 20 Feb 2025 08:30:31 EST

A study finds a troubling rise in 'deaths of despair' in the U.S. from 1999 to 2021, using the International Classification of Diseases. These deaths, defined by 19 underlying causes such as chronic hepatitis, liver cirrhosis, suicide, drug overdoses, and alcohol-related conditions, increased two-and-a-half-fold over two decades. By 2021, deaths of despair would have become the fifth leading cause of death in the U.S., surpassing 176,000 fatalities, and ranking just behind heart disease, cancer, COVID-19 and accidents.

How Livers Regenerate and Why That Matters

Children's Hospital Los Angeles — Fri, 14 Feb 2025 09:35:47 EST

The liver is an underappreciated, but dependable organ with superhero-like powers.

Semaglutide Shows Promise in Reducing Cravings for Alcohol, Heavy Drinking

University of North Carolina School of Medicine — Wed, 12 Feb 2025 19:35:54 EST

Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

The Latest Developments on Cancer Research and Liver Transplantation Outcomes Are Among the Topics to Be Highlighted at the Annual Academic Surgical Congress

University of California, Los Angeles (UCLA), Health Sciences — Mon, 10 Feb 2025 20:35:49 EST

The latest developments in breast lesion detection, robotic cancer resection, liver transplantation, and pancreatic cancer tumor detection are some of the topics to be covered by UCLA doctors and scientists at the 20th annual Academic Surgical Congress (ASC).